Search for: "Valeant Pharmaceutical International, Inc."
Results 1 - 20
of 29
Sorted by Relevance
|
Sort by Date
2 Jul 2007, 9:44 pm
By Donald Zuhn -- Valeant Pharmaceuticals International announced today (July 2, 2007) that it has settled its patent infringement suit with Kali Laboratories, Inc. [read post]
23 May 2018, 6:46 am
A jury in the US District Court for the Southern District of New York [official website] on Tuesday found Valeant Pharmaceuticals International, Inc.'s former executive officer Gary Tanner and former CEO of Philidor Rx Services, LLC (Philidor) Andrew Davenport guilty [press release] for their roles in the multimillion-dollar kickback scheme. [read post]
21 Feb 2019, 9:29 pm
As set forth in the beginning of the opinion: Valeant Pharmaceuticals International, Inc. [read post]
21 Apr 2020, 6:00 am
In Valeant Pharmaceuticals International, Inc. v. [read post]
17 Jan 2018, 5:58 am
Valeant Pharmaceuticals International, Inc., January 12, 2018, Shipp, M.).The complaints are direct actions under Sections 10(b), 18(a), and 20(a) of the Exchange Act, not to be confused with the class action pending before the same court and arising out of the same facts and circumstances. [read post]
11 Jul 2012, 9:50 pm
Watson Pharmaceuticals, Inc. [read post]
26 May 2016, 7:42 am
Nelson, J.D.Valeant Pharmaceuticals International, Inc. [read post]
21 Apr 2020, 6:30 am
In Valeant Pharmaceuticals International, Inc. v. [read post]
1 Dec 2014, 6:05 am
On November 17, 2014, Allergan, Inc. announced a $66 billion merger agreement with Actavis plc, thwarting the pending $53 billion bid for Allergan by Valeant Pharmaceuticals International Inc. [read post]
21 Feb 2019, 8:45 am
Valeant Pharmaceuticals International, Inc. [read post]
8 Feb 2017, 5:45 am
Allergan Inc. has agreed with the SEC that it will admit to securities law violations and will pay a $15 million fine for disclosure violations in its Schedule 14D-9 relating to the unsolicited, public takeover bid for the company made by Valeant Pharmaceuticals International in 2014. [read post]
26 Apr 2012, 9:18 pm
Florida; Watson Pharmaceuticals Inc.; Watson Pharma Inc. [read post]
1 Apr 2016, 6:00 am
Valeant may get bank waivers but risks default with SEC and NYSE by Francine McKenna in MarketWatch Valeant Pharmaceuticals International Inc. may get a waiver from its bank lenders to file its Form 10-K annual report and first-quarter report later than required. [read post]
7 Nov 2015, 2:36 pm
The United States Attorney’s Office for the Eastern District of Pennsylvania and the United States Department of Justice are now requesting information from Eli Lilly and Company, and Valeant Pharmaceuticals International, Inc. [read post]
7 Nov 2015, 2:36 pm
The United States Attorney’s Office for the Eastern District of Pennsylvania and the United States Department of Justice are now requesting information from Eli Lilly and Company, and Valeant Pharmaceuticals International, Inc. [read post]
16 Nov 2017, 6:17 am
Company Name Annual Director Retainer Regeneron Pharmaceuticals $2,074,085 Tesla $1,664,928 The Goldman Sachs Group $575,000 Salesforce.com $550,000 Celgene Corporation $524,871 Reynolds American $496,480 Valeant Pharmaceuticals International $475,000 Allergan PLC $450,000 Everest Re Group, Ltd. $447,030 Oracle $429,172 (more…) [read post]
25 Jan 2022, 3:11 pm
The $1.21 billion Valeant Pharmaceuticals International settlement, which was the largest 2021 settlement and the 9th largest all-time, did not involve a restatement. [read post]
13 May 2021, 2:24 pm
The Valeant court’s revival of the forfeiture rule is creating ripple effects. [read post]
1 Sep 2014, 4:00 am
-based Valeant Pharmaceuticals International Inc. for California-based Allergan Inc. offers Canadian observers a chance to see what hostile takeovers might look like when the target is located in the U.S…. [read post]
9 Mar 2022, 2:06 pm
The largest 2021 settlements included one settlement in excess of $1 billion (the $1.21 billion settlement in the Valeant Pharmaceuticals International case) and four in excess of $100 million (Snap, Inc.: $187.5 million; DaVita, Inc.: $135 million; Allergan plc: $130 million; and GCI Liberty $110 million). [read post]
